医薬品製造委託の世界市場2016-2026...市場調査レポートについてご紹介

【英文タイトル】Pharmaceutical Contract Manufacturing Market 2016-2026 : Discover Revenue Forecasts for Active Ingredient (API) and Finished Dose Formulation (FDF) Services

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation
1.2 Global Pharmaceutical Contract Manufacturing Market Overview
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pharmaceutical Contract Manufacturing
2.1 What is Pharmaceutical Contract Manufacturing?
2.2 The Benefits of Outsourcing in the Pharmaceutical Market
2.3 Pharmaceutical Contract Manufacturing Services
2.4 Strategy and Tactics: The Importance of Outsourcing Wisely
2.5 Trends in Contract Manufacturing, 2016-2026
2.6 Pharmaceutical Contract Manufacturing: Market Segmentation

3. Pharmaceutical Contract Manufacturing: World Market 2015-2026
3.1 Pharmaceutical Contract Manufacturing Market: Historical Performance 2012-2014
3.1.1 Contract Manufacturing is the Most Mature Pharma Outsourcing Sector
3.1.2 The Pharma Contract Manufacturing Market by Sector 2014
3.2 Pharma Contract Manufacturing: Overall Market Forecast 2015-2026
3.2.1 Changing Submarket Shares by Segment 2015-2026
3.2.2 Drivers for Growth in the Contract Manufacturing Market to 2026
3.2.3 Generics: A Driver or Restraint?
3.2.4 Other Contract Manufacturing Services Submarket: Outlook and Forecast 2014-2016
3.2.4.1 Increasing Demand for Formulation Development Services

4. The Contract API Manufacturing Services Submarket 2015-2026
4.1 The Contract API Manufacturing Submarket 2014
4.1.1 Chemical APIs Will Experience Resurgence After the Shift of Focus to Biological APIs
4.1.2 The API Manufacturing Submarket by Sector 2014
4.2 The Contract API Manufacturing Submarket: Outlook and Forecast 2015-2026
4.2.1 Drivers for Growth in the API Submarket to 2026
4.2.2 The Potential for Microreactors in Commercial Manufacturing to 2026
4.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket?
4.2.4 Contract API Manufacturing Submarket Restraint 2016-2026
4.2.4.1 Backwards Integration for Generics Manufacturers
4.3 The Contract Generic API Manufacturing Submarket 2015-2026
4.3.1 The Contract Generic API Manufacturing Submarket Forecast 2015-2026
4.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2026
4.3.2.1 The US Generic Drug User Fee Act and API Manufacturing
4.4 The Contract HPAPI Manufacturing Submarket 2015-2026
4.4.1 Challenges and Opportunities in High Containment Manufacturing
4.4.2 Company Investment into HPAPI Manufacturing Facilities: Growth Increases in the HPAPI Manufacturing Sector
4.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2015-2026
4.4.4 The Contract HPAPI Manufacturing Submarket Drivers and Restraints to 2026

5. The Contract FDF Manufacturing Services Submarket 2015-2026
5.1 The Contract FDF Manufacturing Submarket 2014
5.1.1 Solid Dosage Manufacturing Leads the Market
5.1.2 CMOs Report High Demand for Softgel Formulations
5.2 The Contract FDF Manufacturing Submarket Forecast 2015-2026
5.2.1 Complex Molecule Manufacturing Will Drive Growth to 2026
5.2.2 What Will Restrain Growth in FDF Outsourcing?
5.3 The Contract Solid Dosage Manufacturing Submarket 2015-2026
5.3.1 How Will Revenue for Solid Dosage Manufacturing Grow to 2026?
5.3.2 The Solid Dosage Manufacturing Submarket Drivers and Restraints 2016-2026
5.3.2.1 Will Product Reformulation Drive Growth to 2026?
5.4 The Contract Injectable Dosage Manufacturing Submarket 2015-2026
5.4.1 The Contract Injectable Dosage Manufacturing Submarket Forecast 2015-2026
5.4.1.1 Drug Shortages Offer Opportunity to CMOs in the Short-Term
5.4.2 Demand for Biopharma Manufacturing Will Drive Growth 2016-2026
5.4.2.1 Interest in Antibody-Drug Conjugate Development Is Growing
5.4.2.2 Challenges in Manufacturing Antibody-Drug Conjugates
5.4.3 Lyophilisation and Aseptic Filling Demand Will Rise
5.4.3.1 Will Spray Drying Replace Lyophilisation in FDF Manufacturing?

6. Leading National Markets for Pharmaceutical Contract Manufacturing 2015-2026
6.1 Leading National Markets for Pharmaceutical Contract Manufacturing 2014
6.1.1 Challenges in Assessing the Market: Supply versus Demand
6.1.2 Leading National Pharmaceutical Contract Manufacturing Markets: Revenue Forecasts 2015-2026
6.1.3 Pharmaceutical Manufacturing in the US: Regulatory Oversight 2014
6.1.4 Controlling Foreign Manufacturing Sites
6.1.5 What Impact Will the GDUFA 2012 Have on Foreign Manufacturing?
6.1.6 Outsourcing and US Manufacturing Regulations
6.1.7 Increased Demand for Domestic API Manufacturing?
6.2 The US Contract Manufacturing Market Forecast 2015-2026
6.3 Outlook for Pharmaceutical Contract Manufacturing in the EU
6.3.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing
6.3.2 Regulatory Aspects of Pharma Manufacturing in the EU
6.3.2.1 The European Commission Amends Annex 16
6.3.2.2 The Falsified Medicine Directive: Controlling API Imports
6.3.3 Biopharma Manufacturing Demand Will Rise to 2026
6.3.4 The EU Contract Manufacturing Market Forecast 2015-2026
6.3.5 Germany: The Leading EU Destination for API and FDF Manufacturing
6.3.5.1 Demand for Contract Manufacturing in Germany: Revenue Forecast 2015-2026
6.3.6 CMOs Account for a Third of Manufacturing Sites in France
6.3.6.1 French Pharma Contract Manufacturing Market Forecast 2015-2026
6.3.7 Italy: Strong API Manufacturing Traditions
6.3.7.1 Revenue Forecast for the Italian Pharma Contract Manufacturing Market 2015-2026
6.3.8 Spain: How Will Demand for Manufacturing Services Grow to 2026?
6.3.9 UK: Pharmaceutical Contract Manufacturing Market Forecast 2015-2026
6.4 Pharma Contract Manufacturing in Japan to 2026
6.4.1 Pharmaceutical Manufacturing Regulations in Japan
6.4.1.1 The Pharmaceutical Affairs Law
6.4.2 Greater API Outsourcing to Drive Japanese Market Growth to 2026 In Spite of Currency Devaluation Weakening the Economy

7. Leading Emerging Markets for Pharmaceutical Contract Manufacturing 2015-2026
7.1 Pharmaceutical Contract Manufacturing in Developing Countries
7.1.1 Outsourcing to Emerging National Markets from Developed Markets
7.1.1.1 Demand Will Increase for Services in India and China
7.1.2 Domestic Demand for Pharmaceutical Contract Manufacturing Services
7.1.3 Pharmaceutical Contract Manufacturing: Leading Emerging National Market Forecasts 2015-2026
7.2 Chinese Demand for Pharma Contract Manufacturing Services 2015-2026
7.2.1 Improved Manufacturing Regulations in China
7.2.1.1 New Regulations for Excipients and Guidance for API Manufacturing 2012-2013
7.2.1.2 What Are the Consequences to Stricter Manufacturing Regulations in China?
7.2.2 Chinese CMOs Are Investing in Biopharma Manufacturing
7.2.3 China Pharma Contract Manufacturing Market Forecast 2015-2026
7.3 India: CMOs with Strong Infrastructure and Growing Expertise
7.3.1 Regulatory Outlook for Indian Pharma Manufacturing
7.3.1.1 Stricter Quality Standards to Ensure Compliance with EU Rules
7.3.2 Domestic Manufacturing Dominates the Indian Pharma Market
7.3.3 Demand for Contract Manufacturing in India: Market Forecast 2015-2026
7.4 Brazil: Contract Manufacturing Outlook 2015-2026
7.4.1 Pharmaceutical Manufacturing Regulations in Brazil
7.4.1.1 New Guidelines and Regulations Proposed 2012-2013
7.4.2 Brazil Imports Most of its APIs
7.4.3 Brazil: Pharma Contract Manufacturing Market Forecast 2015-2026
7.5 The Russian Pharma Contract Manufacturing Market 2015-2026
7.5.1 Pharma Manufacturing Regulations in Russia
7.5.1.1 Compliance with GMP in Russia
7.5.2 How Will Demand for Contract Manufacturing Grow in Russia to 2026?
7.6 South Korea: Government Supported Growth
7.6.1 South Korea: Strict GMP Regulations
7.6.2 South Korea: Pharma Contract Manufacturing Market Forecast 2015-2026

8. Leading Companies in the Pharmaceutical Contract Manufacturing Market
8.1 Leading CMOs in the Pharmaceutical Contract Manufacturing Market
8.2 Catalent: Leading CMO
8.2.1 Multiple Expansions and Increased Focus on Biologic Manufacturing
8.3 Lonza: Potential to Lead in ADC Manufacturing
8.3.1 Lonza: Expanding its Capacities to Meet Customer Demand for Biologic Manufacturing
8.4 Evonik Degussa: Specialising in Small Molecules
8.4.1 Developments at Evonik Degussa
8.5 DPx Holdings – DSM and Patheon: Recent Merger Has Strengthened Their Position
8.5.1 Increasing Capacity Tactically and Expanding Worldwide
8.6 Teva: The World’s Largest API Manufacturer
8.6.1 Will Teva Expand into Emerging Markets?
8.7 Boehringer Ingelheim BioXcellence: Boehringer’s Biopharma Manufacturing Division
8.7.1 Adding New Services for Growth
8.8 Famar: A Possible Candidate for Acquisition
8.9 Fareva: A Strategic Shift from Acquisition to Increase in Capacity
8.10 Vetter Pharma: Specialists in Aseptic Filling, Lyophilisation and Siliconisation
8.10.1 Vetter’s Growth: Increasing in Capacity and Market Expansion
8.11 Mylan: A World Leader in Generics Manufacturing

9. Pharmaceutical Contract Manufacturing Industry Trends: Qualitative Analysis from a CMO Perspective 2016-2026
9.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a CMO Perspective 2016-2026
9.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a CMO Perspective 2016-2026
9.3 Pharma Contract Manufacturing Market: STEP Analysis 2016-2026
9.3.1 Social Factors
9.3.2 New Technologies Will Drive Market Growth to 2026
9.3.2.1 Advantages of Single-Use Technologies in Biopharma Manufacturing
9.3.2.2 Green Technology in Contract Manufacturing
9.3.2.3 Drug Delivery Trends and CMOs
9.3.2.4 Biologics Are Causing Increased Demand for Lyophilisation
9.3.2.5 Improving Solubility and Stability for Small Molecules
9.3.2.6 Spray Drying as an Advantageous Alternative to Lyophilisation
9.3.2.7 Hot-Melt Extrusion: A Niche Opportunity
9.3.3 Economic Pressures
9.3.3.1 Developed-Market CMOs Facing Competition from Emerging Markets
9.3.4 Political Issues
9.3.4.1 How Will Regulatory Developments Affect CMOs?
9.4 Trends in Drug Development Affecting CMOs to 2026
9.4.1 Orphan Drug Development: Smaller Manufacturing Capacities
9.4.2 Complex Biologics: Interest in ADCs is Increasing
9.4.3 How Will Biosimilar Market Growth Affect CMOs?
9.4.4 The Future of Small Molecule Outsourcing
9.5 How Will CMOs Expand in the Coming 10 Years?
9.5.1 CMO Consolidation Will Increase
9.5.2 There Will Be More Manufacturing Facilities Available for Acquisition
9.6 Developments in the Manufacturing Process 2016-2026
9.6.1 Rising Interest from Companies in Quality by Design (QbD)
9.6.2 A Move Towards Continuous Manufacturing

10. Pharmaceutical Contract Manufacturing Trends: Qualitative Analysis of the Pharmaceutical Contract Manufacturing Market from a Client Perspective 2016-2026
10.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a Client Perspective 2016-2026
10.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a Client Perspective 2016-2026
10.3 Important Aspects of the Outsourcing Decision
10.3.1 What Factors Will Influence CMO Selection?
10.3.2 CMO-Pharma Partnering Models
10.3.3 Strategic Partnering
10.3.4 Selecting a Local CMO vs. Offshoring
10.3.5 CMOs in Emerging Markets
10.3.6 Good Communication is Vital for Success
10.3.7 Ensuring Protection in Intellectual Property and Tech Transfer
10.3.8 Regulatory Compliance is a Key Deciding Factor for Pharma Clients
10.3.8.1 Regulatory Bodies and Outsourcing
10.3.8.2 Quality Agreement
10.3.8.3 Global Harmonisation Will Improve Compliance
10.4 Trends in Outsourcing Partnerships 2016-2026
10.4.1 Big Pharma and Outsourced Manufacturing
10.4.2 Small and Virtual Pharma Companies
10.4.3 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2026?

11. Research Interviews
11.1 Interview with Gordon Bates, SVP Business Unit Head, Chemical and Microbial Manufacturing, Lonza Pharma & Biotech
11.1.1 Lonza’s Pharmaceutical Contract Manufacturing Capabilities and Experience
11.1.2 Upcoming Trends in Drug Development that Will Affect the Pharmaceutical Contract Manufacturing Industry
11.1.3 The Potential of the Emerging Marketplace
11.1.4 Outlook on Qualities Needed For CMO Success
11.1.5 Industry Trends: Changes in the Next Ten Years
11.2 Interview with Dr Michael Quirmbach, VP, Global Sales and Marketing, CordenPharma International
11.2.1 The Range of CDMO Services Available at CordenPharma
11.2.2 CordenPharma’s Systematic Approach Navigates the Challenges of HPAPI Manufacturing
11.2.3 Future Trends in the Developed and Emerging Markets for Contract Manufacturing
11.2.4 Certain Manufacturing Sectors are Primed for Growth While Others Decline
11.2.5 Factors for CDMO Success in the Contract Manufacturing Market

12. Conclusions
12.1 The World Pharmaceutical Contract Manufacturing Market
12.2 Outlook for the Market to 2026
12.2.1 Rising Demand for High Value Services 2016-2026
12.2.2 Demand Will Be Highest Among Developed-Market Clients
12.3 Which New Technologies Will Stimulate Demand to 2026?


【レポート販売概要】

■ タイトル:医薬品製造委託の世界市場2016-2026
■ 英文:Pharmaceutical Contract Manufacturing Market 2016-2026 : Discover Revenue Forecasts for Active Ingredient (API) and Finished Dose Formulation (FDF) Services
■ 発行日:2016年3月
■ 調査会社:visiongain
■ 商品コード:VGAIN6041532
■ 調査対象地域:グローバル
  • 膵外分泌機能不全(Exocrine Pancreatic Insufficiency):世界の治験レビュー(2015年上半期版)
    Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Exocrine Pancreatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Exocrine Pancreatic Insufficiency. It i …
  • 電撃防止エンクロージャの世界市場2015-2019
    About Electrical Enclosure Equipment Electrical enclosure is used to protect electrical equipment such as power generators, transmitters, power distribution systems, and other electrical equipment. There are two types of electrical enclosures: metallic and non-metallic. Power generators, transmitters, and power distribution systems use electrical enclosure as a cabinet to mount switches, displays, …
  • 世界のヘアケア市場動向(2012-2016)
    TechNavio’s analysts forecast the Global Hair Care market to grow at a CAGR of 6.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is increasing hair and scalp problems. The Global Hair Care market has also been witnessing the emergence of online retail for hair care products. However, the intense competition among vendors could pose a challenge to the …
  • データセンター向けUPSの世界市場:製品別(大規模データセンター用UPS、中規模データセンター用UPS、小規模データセンター用UPS、その他)、地域別予測
    Global Data Center UPS Market to reach USD 8.18 billion by 2025. Global Data Center UPS Market valued approximately USD 4.19 billion in 2016 is forecasted to grow with a healthy growth rate of more than 7.72% over the forecast period 2018-2025. The major factors speculated to augment the markets are rising demand for uninterrupted power to secure efficient operations in financial institutions, ban …
  • プレミアムラガービールの世界市場2019-2023
    About this market Premium lagers are increasingly preferred by consumers because of their authenticity, taste, brand story, visual identity, and experience. The premium lager many vendors has gained high popularity among consumers because of its authentic taste. The adoption of the keg packaging and dispense format, especially by small producers, has been an important factor behind the increasing …
  • 包装向けデジタルプリンティングの世界市場2017-2021
    About Digital PrintingDigital printing is a printing technique in which a digital-based image is directly printed on a medium. In the market discussed, the media will be various packaging products, such as food and beverage packaging and personal care products packaging. Digital printing market for packaging is an emerging market and has several advantages over traditional methods of printing (ana …
  • 歯科診断・手術装置の世界市場2019-2023
    About this market The worldwide prevalence of dental diseases and the associated risk factors are increasing significantly. The prevalence of oral cancer is also increasing in many countries. The prevalence of these dental diseases significantly increases with age. Globally, the number of old people is also growing rapidly owing to the rise in average life expectancy. In addition, the prevalence o …
  • 対話型システムの世界市場予測・分析2020-2024
    Global Conversational Systems Market: About this market Technavio’s conversational systems market analysis considers sales from both text and voice types. Our study also finds the sales of conversational systems in APAC, Europe, MEA, North America, and South America. In 2018, the text segment had a significant market share, and this trend is expected to continue over the forecast period. Factors s …
  • アルミニウム複合材パネルの世界市場:用途別(鉄道、自動車、建設、広告掲示板(サイネージ))、、地域別予測
    Global Aluminum Composite Panels Market to reach USD 8.55 billion by 2025. Global Aluminum Composite Panels Market valued approximately USD 4.53 billion in 2016 is forecasted to grow with a healthy growth rate of more than 7.32% over the forecast period 2018-2025. The major factors contemplated to augment the markets are rapid urbanization, increasing building and construction activities, and dema …
  • 誘電体エッチング装置の世界市場
    About Dielectric EtchersDielectric Etcher: Dielectric etcher is a semiconductor etching equipment used for etching dielectric materials. The process involves etching with the help of dry etch tools, such as inductively coupled plasma or transformer coupled plasma type chambers, operating at low pressures. Carbon monoxide is used in many dielectric etch processes. Technavio’s analysts forecast the …
  • 世界の雲母市場:市場規模、動向、メーカー動向
    Scope The report presents a thorough study of miсa, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing miсa production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: miсa production in th …
  • 人工肩関節置換術:企業と競争環境
    MediPoint: Total Shoulder Replacement - Current and Future Players Summary GlobalData has released its medical devices report, "MediPoint: Total Shoulder Replacement - Current and Future Players". The report is an essential source of information and analysis on the global total shoulder replacement market. Although sluggish economic growth has hindered the large-joint replacement market in the Uni …
  • UCaaSの世界市場2017-2021
    ABSTRACTAbout Unified Communication UCaaS is a cloud-based deployment model of unified communications (UC) technology such as enterprise audio and video conferencing, hosted VoIP, and cloud private branch exchange (PBX). UCaaS is implemented in enterprises to communicate and collaborate globally in a cloud-based ICT ecosystem. Technavio’s analysts forecast the global unified communication as a ser …
  • グローバル鉱業の景況感レポート(2015年上半期)
    Summary “Mining Business Confidence Report H1 2015” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the mining industry. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes …
  • ウェアラブル・ゲームの世界市場:企業、ゲームデバイス、ソリューション
    Wearable gaming represents an emerging entrant into the digital entertainment market that is best defined from a mobile gaming perspective. Non-wearable mobile gaming is played on various wireless devices (smartphones, tablets, phablets, etc.), which have limited interface capabilities compared to desktop, laptop, or console gaming. In many ways, wearable technology causes even more limitations, b …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。